Benigne Prostatahyperplasie – Diagnostik in der Praxis und konservative Therapieansätze

Coyne KS, Sexton CC, Thompson CL, Milsom I, Irwin D, Kopp ZS, Chapple CR, Kaplan S, Tubaro A, Aiyer LP, Wein AJ (2009) The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int 104:352–360

Flanigan RC et al (1998) 5‑year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 160(1):12–16 (discussion 16–7)

EAU Guidelines on Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-the-Management-of-Non-neurogenic-Male-LUTS-2018-large-text.pdf. Zugegriffen: 22. April 2019

Uvelius B, Arner A (1997) Changed metabolism of detrusor muscle cells from obstructed rat urinary bladder. Scand J Urol Nephrol Suppl 184:59–65

Irwin DE (2006) Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int 97(1):96–100

Rao PK, Gao T, Pohl M, Jones JS (2010) Dipstick pseudohematuria: unnecessary consultation and evaluation. J Urol 183:560–564

Gasser T, Iselin C, Jichlinksi P, Kreienbühl B, Merz V, Recker F, Schmid HP, Stoffel F, Strebel R, Sulser T, Thalmann G (2012) PSA-Bestimmung – Empfehlungen der Schweizerischen Gesellschaft für Urologie (SGU). Swiss Med Forum 12(06):126–128. https://doi.org/10.4414/smf.2012.07772

Roehrborn CG et al (1999) Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia. Urology 53(3):581–589

Jacobsen SJ et al (1999) Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 162(4):1301–1306

Clement KD et al (2015) Invasive urodynamic studies for the management of lower urinary tract symptoms (LUTS) in men with voiding dysfunction. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011179.pub2